RT Journal Article
SR Electronic
T1 Directed exploration is elevated in affective disorders but reduced by an aversive interoceptive state induction
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.19.24309110
DO 10.1101/2024.06.19.24309110
A1 Li, Ning
A1 Lavalley, Claire A.
A1 Chou, Ko-Ping
A1 Chuning, Anne E.
A1 Taylor, Samuel
A1 Goldman, Carter M.
A1 Torres, Taylor
A1 Hodson, Rowan
A1 Wilson, Robert C.
A1 Stewart, Jennifer L.
A1 Khalsa, Sahib S.
A1 Paulus, Martin P.
A1 Smith, Ryan
YR 2024
UL http://medrxiv.org/content/early/2024/06/20/2024.06.19.24309110.1.abstract
AB Elevated anxiety and uncertainty avoidance are known to exacerbate maladaptive choice in individuals with affective disorders. However, the differential roles of state vs. trait anxiety remain unclear, and underlying computational mechanisms have not been thoroughly characterized. In the present study, we investigated how a somatic (interoceptive) state anxiety induction influences learning and decision-making under uncertainty in individuals with clinically significant levels of trait anxiety. A sample of 58 healthy comparisons (HCs) and 61 individuals with affective disorders (iADs; i.e., depression and/or anxiety) completed a previously validated explore-exploit decision task, with and without an added breathing resistance manipulation designed to induce state anxiety. Computational modeling revealed a pattern in which iADs showed greater information-seeking (i.e., directed exploration; Cohen’s d=.39, p=.039) in resting conditions, but that this was reduced by the anxiety induction. The affective disorders group also showed slower learning rates across conditions (Cohen’s d=.52, p=.003), suggesting more persistent uncertainty. These findings highlight a complex interplay between trait anxiety and state anxiety. Specifically, while elevated trait anxiety is associated with persistent uncertainty, acute somatic anxiety can paradoxically curtail exploratory behaviors, potentially reinforcing maladaptive decision-making patterns in affective disorders.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was funded by National Institute of General Medical Sciences (P20GM121312 [R.S. and M.P.P.]) and the Laureate Institute for Brain Research.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:WCG Institutional Review Board of the Laureate Institute for Brain Research gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.